InvestorsHub Logo
Followers 46
Posts 3422
Boards Moderated 0
Alias Born 10/15/2013

Re: Amatuer17 post# 187

Monday, 03/19/2018 7:57:59 AM

Monday, March 19, 2018 7:57:59 AM

Post# of 427
Alzheon files for $80M IPO to take once-failed Alzheimer’s drug into PhIII – Endpoints News

https://endpts.com/alzheon-files-for-80m-ipo-to-take-once-failed-alzheimers-drug-into-phiii/

“It doesn’t help Alzheon’s odds that its pursuing the amyloid beta hypothesis, which has defeated every drug thrown at it so far in a pivotal study. Eli Lilly $LLY tried this route for treating Alzheimer’s with solanezumab, but scrapped the program for treating symptomatic patients a couple years ago thanks to a series of Phase III failures. The drug is currently being studied to see if it can delay the development of preclinical patients.”

ARFXF Phase 1 next year could get some noticeable attention.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMN News